Education
About Us
Working with TipRanks
Follow Us
Maky Zanganeh Insider Profile
53 Followers
Maky Zanganeh, COO at Pharmacyclics, holds 591.49M shares in Summit Therapeutics (Ticker: SMMT), holds 873.47K shares in Pulse Biosciences (Ticker: PLSE), holds 0.00 shares in Pharmacyclics (Ticker: PCYC).
Profitable Transactions
12 out of 21 Profitable Transactions
Average Return
+99.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Maky Zanganeh holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Dec 13, 2023 - Dec 13, 2024
Return:+661.90%
The most profitable trade made by Maky Zanganeh
Maky Zanganeh's Trading History
Pharmacyclics
May 27, 2015
―
Uninformative Sell
3.92M
―
Pulse Biosciences
Feb 11, 2025
Director
Informative Buy
662.66K
$13.57M
Summit Therapeutics
Jun 02, 2025
Co- CEO, Director, Ten Percent Owner
Uninformative Buy
196.80K
$14.02B
List of latest transactions for each holding click on a transaction to see Maky Zanganeh's performance on stock
You May Also Like
Maky Zanganeh insider profile FAQ
What is the percentage of profitable transactions made by Maky Zanganeh?
The percentage of profitable transactions made by Maky Zanganeh is 57%.
What is the average return per transaction made by Maky Zanganeh?
The average return per transaction made by Maky Zanganeh is 99.10%.
What stocks does Maky Zanganeh hold?
Maky Zanganeh holds: PCYC, PLSE, SMMT stocks.
What was Maky Zanganeh’s latest transaction?
Maky Zanganeh latest transaction was an Uninformative Buy of $196.80K.
What was Maky Zanganeh's most profitable transaction?
Maky Zanganeh’s most profitable transaction was an Informative Buy of SMMT stock on December 13, 2023. The return on the trade was 661.90%.
What is Maky Zanganeh's role in Pharmacyclics?
Maky Zanganeh's role in Pharmacyclics is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.